Literature DB >> 22014990

Injectable neurotoxins and fillers: there is no free lunch.

Jason Emer1, Heidi Waldorf.   

Abstract

Injection of neurotoxins and filling agents for the treatment of facial aesthetics has increased dramatically during the past few decades due to an increased interest in noninvasive aesthetic improvements. An aging but still youth-oriented population expects effective treatments with minimal recovery time and limited risk of complications. Injectable neurotoxins and soft tissue stimulators and fillers have filled this niche of "lunch-time" procedures. As demand for these procedures has increased, supply has followed with more noncore cosmetic specialty physicians, as well as unsupervised ancillary staff, becoming providers and advertising them as easy fixes. Despite an excellent record of safety and efficacy demonstrated in scores of published studies, injectable agents do carry risks of complications. These procedures require a physician with in-depth knowledge of facial anatomy and injection techniques to ensure patient safety and satisfaction. In general, adverse events are preventable and technique-dependent. Although most adverse events are minor and temporary, more serious complications can occur. The recognition, management, and treatment of poor outcomes are as important as obtaining the best aesthetic results. This review addresses important considerations regarding the complications of injectable neurotoxins and fillers used for "lunch-time" injectable procedures.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014990     DOI: 10.1016/j.clindermatol.2011.08.005

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  8 in total

1.  Aesthetic Dermatologic Treatments: Consensus from the Experts.

Authors:  W Philip Werschler; Jacqueline M Calkin; David A Laub; Tess Mauricio; Vic A Narurkar; Phoebe Rich
Journal:  J Clin Aesthet Dermatol       Date:  2015-10

Review 2.  Clinical uses of botulinum toxin A in smile aesthetic modification.

Authors:  S N Delpachitra; A W Sklavos; M Dastaran
Journal:  Br Dent J       Date:  2018-09-28       Impact factor: 1.626

3.  Frontoplasty Technique for the Mestizo Patient.

Authors:  Shino Bay Aguilera; Mehreen Hall; Dayana Carolina Suárez Carvajal; Andres Gaviria
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

Review 4.  The Aetiopathogenesis of Late Inflammatory Reactions (LIRs) After Soft Tissue Filler Use: A Systematic Review of the Literature.

Authors:  Y Bachour; J A Kadouch; F B Niessen
Journal:  Aesthetic Plast Surg       Date:  2021-04-28       Impact factor: 2.326

5.  Complications of minimally invasive cosmetic procedures: prevention and management.

Authors:  Lauren L Levy; Jason J Emer
Journal:  J Cutan Aesthet Surg       Date:  2012-04

6.  Delayed immune mediated adverse effects to hyaluronic Acid fillers: report of five cases and review of the literature.

Authors:  Ora Bitterman-Deutsch; Leonid Kogan; Faris Nasser
Journal:  Dermatol Reports       Date:  2015-03-30

7.  The use of algeness in the face and neck: a safe, alternative filler for cosmetics and reconstruction.

Authors:  Chrisanthi Karapantzou; Mark Jakob; Brian Kinney; Joan Vandeputte; Joao Pedro Vale; Martin Canis
Journal:  Ann Transl Med       Date:  2020-03

Review 8.  Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.

Authors:  Greg J Goodman; Steven Liew; Peter Callan; Sarah Hart
Journal:  Australas J Dermatol       Date:  2020-03-22       Impact factor: 2.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.